Health & Biotech Scott Power: Which small medtech lifted 70pc this week after US contract win? December 6, 2024 Micro-X's 70% climb this week proves momentum is returning to the ASX healthcare sector, notes Morgans analyst Scott Power. The biggest company you’ve never head of December 6, 2024 Valued at nearly $27bn, Pro Medicus is larger than Coles and twice the size of Qantas. And it remains a… Race submits key ethics application for phase I cancer trial December 6, 2024 Race Oncology has submitted a human ethics regulatory package for its phase I trial in solid tumour patients using the… US reimbursement rate set for Lumos point-of-care respiratory test December 5, 2024 A reimbursement rate has been set by the Centers for Medicare and Medicaid Services Panel in the US for Lumos’s… Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump December 5, 2024 The biotech sector is fast emerging from its two-year funk amid a rush of news about clinical trials, approvals and… Dr Boreham’s Crucible: Will ditching its baggage help this pancreatic cancer-targeting outfit soar? December 5, 2024 Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA in… Could Trump’s second act boost these ASX psychedelic stocks? December 5, 2024 President-elect Donald Trump’s return to the White House might favourably impact the psychedelics sector with ASX stocks in the spotlight. Health Check: Pro Medicus founders cashed up for the festive season December 4, 2024 Pro Medicus founders Dr Sam Hupert and Anthony Hall have lightened their holdings, but they still account for close to… Imagion set to improve cancer detection through molecular MRI December 4, 2024 Imagion Biosystems will use funds from a recent $3m capital raise to advance its cancer-diagnosis platform MagSense closer to market. ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns December 4, 2024 The ASX 200 Health Care Index rose 2.89% in November and is up 9.54%. 'Momentum is starting to return,' says… Next»